Genenta Science S.p.A. stock surged after ANEMOCYTE partnership. Discover temferon's cancer trial updates and what’s next.
Genenta Science SpA Sponsored ADR ( ($GNTA) ) just unveiled an update. On October 29, 2025, Genenta Science S.p.A. held its Ordinary and ...
Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. Its lead product ...
Genenta Science shares surged 300% in premarket trading on Friday after announcing an expanded collaboration with ANEMOCYTE.
Detailed price information for Genenta Science S.P.A. ADR (GNTA-Q) from The Globe and Mail including charting and trades.
Genenta Science (NasdaqCM:GNTA) recently drew widespread attention after announcing an expanded partnership with Anemocyte, centered on advancing off-the-shelf lentiviral vector Plasmid DNA technology ...
We recently published a list of 12 Best Italian Stocks to Buy in 2025. In this article, we are going to take a look at where Genenta Science S.p.A. (NASDAQ:GNTA) stands against other best Italian ...
GNTA is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of GNTA shares has decreased $0.18 since the market last closed. This is a 5.92 ...
The clinical-stage biotechnology firm revealed it has entered into a securities purchase agreement with institutional investors to sell 4,285,715 American Depositary Shares at $3.50 per ADS. The ...
We recently published a list of 10 Best Italian Stocks To Buy Now. In this article, we are going to take a look at where Genenta Science S.p.A. (NASDAQ:GNTA) stands against the other best Italian ...
Detailed price information for Genenta Science S.P.A. ADR (GNTA-Q) from The Globe and Mail including charting and trades.
Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is exempt of filing insider holdings with ...